PPAR-α agonists are still on the rise: an update on clinical and experimental findings-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PPAR-α agonists are still on the rise: an update on clinical and experimental findings

Published:2017-04-11 Issue:5 Volume:26 Page:593-602
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Ferri Nicola¹,Corsini Alberto²³,Sirtori Cesare⁴,Ruscica Massimiliano²

Affiliation:

1. Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Padua, Italy

2. Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy

3. Multimedica IRCCS, Milano, Italy

4. Centro Dislipidemie, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy

Funder

Fondazione Cariplo

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1312339

Reference110 articles.

1. Interpretation of the evidence for the efficacy and safety of statin therapy

2. Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

3. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

4. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants.

5. Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies;Frontiers in Nutrition;2024-03-19

2. The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease;European Cardiology Review;2023-09-28

3. Insulin sensitizers in 2023: lessons learned and new avenues for investigation;Expert Opinion on Investigational Drugs;2023-09-02

4. Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study;Nutrition, Metabolism and Cardiovascular Diseases;2023-07

5. Gemfibrozil palliates adriamycin-induced testicular injury in male rats via modulating oxidative, endocrine and inflammatory changes in rats;Tissue and Cell;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3